These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9340161)

  • 1. [Neuropsychological deterioration in Huntington's disease].
    Deus-Yela J; Pujol J; Espert R
    Rev Neurol; 1997 Aug; 25(144):1257-68. PubMed ID: 9340161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Huntington chorea. Clinical correlations and preliminary neuropsychological data].
    Fragassi NA; Stanzione M; Angelini R; Di Maio L
    Acta Neurol (Napoli); 1992; 14(4-6):530-6. PubMed ID: 1293994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WAIS-R features of preclinical Huntington's disease: implications for early detection.
    Robins Wahlin TB; Larsson MU; Luszcz MA; Byrne GJ
    Dement Geriatr Cogn Disord; 2010; 29(4):342-50. PubMed ID: 20389076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Executive dysfunction in Huntington's disease].
    Redondo Vergé L; Brown RG; Chacón J
    Rev Neurol; 2001 May 16-31; 32(10):923-9. PubMed ID: 11424047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early cognitive deficits in Swedish gene carriers of Huntington's disease.
    Robins Wahlin TB; Lundin A; Dear K
    Neuropsychology; 2007 Jan; 21(1):31-44. PubMed ID: 17201528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Self-awareness of deficits in Huntington's and Parkinson's disease].
    Sitek EJ; Sławek J; Wieczorek D
    Psychiatr Pol; 2008; 42(3):393-403. PubMed ID: 19899567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic features of Huntington's disease-like 2.
    Walker RH; Jankovic J; O'Hearn E; Margolis RL
    Mov Disord; 2003 Dec; 18(12):1527-30. PubMed ID: 14673892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of rivastigmine on motor and cognitive impairment in Huntington's disease.
    de Tommaso M; Specchio N; Sciruicchio V; Difruscolo O; Specchio LM
    Mov Disord; 2004 Dec; 19(12):1516-8. PubMed ID: 15390067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and neuropsychological characteristics of Huntington's disease: a review].
    Arango-Lasprilla JC; Iglesias-Dorado J; Lopera F
    Rev Neurol; 2003 Oct 16-31; 37(8):758-65. PubMed ID: 14593636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cognitive deterioration in Huntington disease].
    Redondo-Vergé L
    Rev Neurol; 2001 Jan 1-15; 32(1):82-5. PubMed ID: 11293108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Huntington's disease.
    Grove M; Vonsattel JP; Mazzoni P; Marder K
    Sci Aging Knowledge Environ; 2003 Oct; 2003(43):dn3. PubMed ID: 14586062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cognitive assessment of asymptomatic Huntington's disease carriers].
    Gómez-Tortosa E; del Barrio Alba A; Sánchez Pernaute R; Benítez J; Barroso A; García Yébenes J
    Neurologia; 1997; 12(6):226-31. PubMed ID: 9303588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Objective assessment of motor slowness in Huntington's disease: clinical correlates and 2-year follow-up.
    van Vugt JP; Piet KK; Vink LJ; Siesling S; Zwinderman AH; Middelkoop HA; Roos RA
    Mov Disord; 2004 Mar; 19(3):285-97. PubMed ID: 15022182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A neuropsychological study of Huntington's disease in families in Antioquia, Colombia].
    Arango-Lasprilla JC; Iglesias-Dorado J; Moreno S; Lopera F
    Rev Neurol; 2003 Jul 1-15; 37(1):7-13. PubMed ID: 12861500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two years' follow-up of rivastigmine treatment in Huntington disease.
    de Tommaso M; Difruscolo O; Sciruicchio V; Specchio N; Livrea P
    Clin Neuropharmacol; 2007; 30(1):43-6. PubMed ID: 17272969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life in Huntington's disease: Which factors matter most?
    Ho AK; Gilbert AS; Mason SL; Goodman AO; Barker RA
    Mov Disord; 2009 Mar; 24(4):574-8. PubMed ID: 19097181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalamic atrophy in Huntington's disease co-varies with cognitive performance: a morphometric MRI analysis.
    Kassubek J; Juengling FD; Ecker D; Landwehrmeyer GB
    Cereb Cortex; 2005 Jun; 15(6):846-53. PubMed ID: 15459079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral symptoms associated with Huntington's disease.
    Anderson KE; Marshall FJ
    Adv Neurol; 2005; 96():197-208. PubMed ID: 16383221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visuospatial cognition in Huntington's disease.
    Mohr E; Brouwers P; Claus JJ; Mann UM; Fedio P; Chase TN
    Mov Disord; 1991; 6(2):127-32. PubMed ID: 1829137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bradykinesia is not a "systematic" feature of adult-onset Huntington's disease; implications for basal ganglia pathophysiology.
    Fenney A; Jog MS; Duval C
    Brain Res; 2008 Feb; 1193():67-75. PubMed ID: 18177845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.